心血管疾病风险预测工具在炎症性关节炎与银屑病中的预测准确性:基于临床实践研究数据链的观察性验证研究
该观察性验证研究利用临床实践研究数据链Aurum数据库,评估QRISK-3、Framingham风险评分(FRS)和Reynolds风险评分(RRS)在类风湿关节炎(RA)、银屑病关节炎(PsA)、银屑病、强直性脊柱炎(AS)及骨关节炎(OA)中的10年心血管风险预测表现。结果显示QRISK3在各病种中区分度尚可,但三种工具在RA、AS和银屑病病患者中的预测准确性普遍低于原发表报告,且OA患者预测准确性亦较低,提示炎症并非表现不佳的唯一原因,可能需要疾病特异性风险预测工具。
要点
- QRISK3在RA中时间依赖AUC为0.752,AS为0.794,PsA为0.764,银屑病为0.815,OA为0.698。
- FRS对RA患者校准尚可但低估风险,RRS倾向低估风险,QRISK3高估风险尤其在高危个体。
- RA、AS和银屑病患者使用三种工具预测准确性普遍低于原发表报告,OA患者亦较低。
核心结论
- RA、AS和银屑病病患者使用QRISK-3、FRS和RRS预测心血管风险的准确性普遍低于原发表报告。
- OA患者预测准确性亦较低,提示炎症并非预测表现不佳的唯一原因。
- 可能需要疾病特异性风险预测工具。
研究设计与样本
- 观察性验证研究,利用临床实践研究数据链(CPRD)Aurum数据库的初级保健记录识别各疾病个体。
- 使用QRISK-3、FRS和RRS计算10年心血管风险,评估各工具在各疾病中的区分度和校准度。
- 纳入RA、PsA、银屑病、AS患者,并以OA作为非炎症对照。
主要发现
- QRISK3时间依赖AUC:RA为0.752(95%CI 0.734-0.777),AS为0.794(95%CI 0.764-0.812),PsA为0.764(95%CI 0.741-0.791),银屑病为0.815(95%CI 0.789-0.835),OA为0.698(95%CI 0.670-0.717)。
- FRS的AUC与QRISK3相似,RRS的AUC略低。
- FRS对各疾病校准尚可,但低估RA患者风险。
- RRS倾向低估心血管风险,QRISK3高估心血管风险,尤其对最高危个体。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Cardiovascular risk prediction tools developed for the general population often underperform for individuals with RA, and their predictive accuracy are unclear for other inflammatory conditions that also have increased cardiovascular risk. We investigated the performance of QRISK-3, the Framingham Risk Score (FRS) and the Reynolds Risk Score (RRS) in RA, psoriatic disease (PsA and psoriasis) and AS. We considered OA as a non-inflammatory comparator. METHODS: We utilized primary care records from the Clinical Practice Research Datalink (CPRD) Aurum database to identify individuals with each condition and calculated 10-year cardiovascular risk using each prediction tool. The discrimination and calibration of each tool was assessed for each disease. RESULTS: The time-dependent area under the curve (AUC) for QRISK3 was 0.752 for RA (95% CI 0.734-0.777), 0.794 for AS (95% CI 0.764-0.812), 0.764 for PsA (95% CI 0.741-0.791), 0.815 for psoriasis (95% CI 0.789-0.835) and 0.698 for OA (95% CI 0.670-0.717), indicating reasonably good predictive performance. The AUCs for the FRS were similar, and slightly lower for the RRS. The FRS was reasonably well calibrated for each condition but underpredicted risk for patients with RA. The RRS tended to underpredict CVD risk, while QRISK3 overpredicted CVD risk, especially for the most high-risk individuals. CONCLUSION: CVD risk for individuals with RA, AS and psoriatic disease was generally less accurately predicted using each of the three CVD risk prediction tools than the reported accuracies in the original publications. Individuals with OA also had less accurate predictions, suggesting inflammation is not the sole reason for underperformance. Disease-specific risk prediction tools may be required.
引用
- Hughes DM, Coronado JIC, Schofield P, et al. The predictive accuracy of cardiovascular disease risk prediction tools in inflammatory arthritis and psoriasis: an observational validation study using the Clinical Practice Research Datalink. Rheumatology (Oxford). 2024. PMID: 37966910. doi:10.1093/rheumatology/kead610
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。